JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.04% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.55% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
PUT
Moody's
MCO
$84B
| $1.41M | ﹤0.01% |
+5,200
| New | +$1.56M |
|
|
MOND
3652
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $1.41M | ﹤0.01% |
141,964
-807,125
| -85% | -$7.94M |
|
3653
C3.ai
AI
$1.54B
| $1.41M | ﹤0.01% |
77,247
-6,723
| -8% | -$124K |
|
3654
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
| $1.41M | ﹤0.01% |
52,059
+19,784
| +61% | +$563K |
|
|
BCYC
3655
Bicycle Therapeutics
BCYC
$273M
| $1.4M | ﹤0.01% |
83,458
+73,555
| +743% | +$1.55M |
|
3656
Enova International
ENVA
$6.61B
| $1.4M | ﹤0.01% |
48,603
+3,325
| +7% | +$110K |
|
3657
Q32 Bio
QTTB
$451M
| $1.4M | ﹤0.01% |
39,442
-1,271
| -3% | -$43.4K |
|
3658
Franklin Senior Loan ETF
FLBL
$859M
| $1.39M | ﹤0.01% |
+60,031
| New | +$1.45M |
|
|
CCXI
3659
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.39M | ﹤0.01% |
56,060
-62,576
| -53% | -$1.38M |
|
3660
Matthews International
MATW
$725M
| $1.39M | ﹤0.01% |
48,392
-14,384
| -23% | -$440K |
|
|
NVEE
3661
DELISTED
NV5 Global
NVEE
| $1.39M | ﹤0.01% |
47,436
+9,060
| +24% | +$272K |
|
3662
Perion Network
PERI
$385M
| $1.39M | ﹤0.01% |
76,181
-14,805
| -16% | -$307K |
|
3663
Ooma
OOMA
$572M
| $1.38M | ﹤0.01% |
116,771
-15,304
| -12% | -$203K |
|
3664
CryoPort
CYRX
$772M
| $1.38M | ﹤0.01% |
44,549
+11,320
| +34% | +$301K |
|
3665
Fastly Inc
FSLY
$4.77B
| $1.38M | ﹤0.01% |
118,955
-126,149
| -51% | -$1.78M |
|
3666
Recursion Pharmaceuticals
RXRX
$1.69B
| $1.38M | ﹤0.01% |
169,350
+42,311
| +33% | +$283K |
|
3667
CALL
NXP Semiconductors
NXPI
$59.2B
| $1.38M | ﹤0.01% |
9,300
| – | – |
|
|
NKLA
3668
DELISTED
Nikola Corporation Common Stock
NKLA
| $1.38M | ﹤0.01% |
9,647
+2,587
| +37% | +$529K |
|
3669
Globalstar
GSAT
$10.7B
| $1.38M | ﹤0.01% |
74,541
+16,550
| +29% | +$307K |
|
3670
First Internet Bancorp
INBK
$254M
| $1.37M | ﹤0.01% |
37,306
-634
| -2% | -$24.4K |
|
3671
AMERISAFE
AMSF
$513M
| $1.37M | ﹤0.01% |
26,389
+3,452
| +15% | +$168K |
|
3672
Cannae Holdings
CNNE
$635M
| $1.37M | ﹤0.01% |
70,935
+7,265
| +11% | +$152K |
|
|
CLRM
3673
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
| $1.37M | ﹤0.01% |
139,494
-60,734
| -30% | -$596K |
|
|
CMBM
3674
DELISTED
Cambium Networks
CMBM
| $1.37M | ﹤0.01% |
93,419
+21,062
| +29% | +$332K |
|
|
AEVA
3675
Aeva Technologies
AEVA
$1.62B
| $1.37M | ﹤0.01% |
87,345
+67,215
| +334% | +$1.11M |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.